KLA Corp (KLAC) stock analysis
Close on Nov 11, 2026Market cap $209.79BP/E 40.3Yield 0.50%
StockData Score
Prices as of Nov 11, 2026How the score works
Solid15 of 30 checks passed
KLA passes 15 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 4/6
- Past performance
- 5/6
- Financial health
- 2/6
- Dividend
- 4/6
What stands out
Return on equity over 15%
Return on equity was 91.4% over the last twelve months and averaged 114% over five years.
Earnings grew over 5 years
Net income grew 18.4% a year on average over the last five fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 14.9% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 24.1% over the last twelve months, against a 5-year average of 18.4% a year.
What to watch
Margin of safety under 20%
The price is 28.7% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $161.01 is above our fair value estimate of $125.09.
Revenue growing under 10% a year
Revenue grew 9.0% a year over the last three fiscal years, short of the 10% we look for.
P/E above its 5-year median
KLA's P/E of 40.3 is above its own 5-year median of 29.3.
Valuation0/6
P/E above its 5-year median
KLA's P/E of 40.3 is above its own 5-year median of 29.3.
P/E above the industry
KLA's P/E of 40.3 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.
EV/EBITDA above its 5-year median
KLA's EV/EBITDA of 30.6 is above its 5-year median of 21.0.
P/B above the industry
KLA's price-to-book of 32.16 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.
Trading above fair value
The share price of $161.01 is above our fair value estimate of $125.09.
Margin of safety under 20%
The price is 28.7% above fair value, so there is no margin of safety.
Growth4/6
Revenue growing under 10% a year
Revenue grew 9.0% a year over the last three fiscal years, short of the 10% we look for.
EPS growing 10%+ a year
Diluted EPS grew 14.9% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 24.1% over the last twelve months, against a 5-year average of 18.4% a year.
Growing faster than the industry
Revenue grew 15.8% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.
Guidance issued
The latest outlook (second quarter of fiscal 2027 Total revenues, Oct 28, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin improving
Gross margin was 61.5% over the last twelve months, against 61.3% a year earlier.
Past performance5/6
Return on equity over 15%
Return on equity was 91.4% over the last twelve months and averaged 114% over five years.
Return on invested capital
Needs operating income and invested capital.
Return on equity above the industry
KLA's return on equity of 91.4% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.
Earnings grew over 5 years
Net income grew 18.4% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 36.2% over the last twelve months, against a 5-year average of 33.1%.
Net margin above the industry
KLA's net margin of 36.2% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.
Financial health2/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 2.76 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 12.21; above 3 is the safe zone and below 1.8 the distress zone.
Dividend4/6
Pays a dividend
KLA paid dividends worth 0.5% of the share price over the last twelve months.
Yield below Treasuries
The 0.5% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; KLA yields 0.5%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Covered by earnings
Dividends take 21.1% of net income.
Covered by free cash flow
Dividends take 27.5% of free cash flow.
Fair value
How we estimate itOur estimate per share
$125.09
The share price is 29% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 32.9× | 29.3× | 36.5× | $131.45 | 53% |
| EV/EBITDA | 22.4× | 21.0× | 23.7× | $117.81 | 47% |
| Earnings powerleft out, too far from the others | 13.7% cost of equity | – | – | $19.68 | – |
| Fair value | $125.09 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 29.3
- Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $2.10B
- Value traded per 1% price move
- $754.43M
Downside
High risk
- Typical loss in a bad month
- 28.3%
- Volatility (annualized)
- 64%
- Sharpe ratio, 1 year
- 0.44
- Beta to the S&P 500 (5Y)
- 1.77
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2012 to 2026
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +11.7% | +9.0% | +14.4% | +16.4% | |
| Gross profit | +12.4% | +9.9% | +15.0% | +16.4% | |
| Net income | +18.9% | +12.6% | +18.4% | +21.2% | |
| EPS, diluted | +20.4% | +14.9% | +22.3% | +23.3% | |
| Free cash flow | +0.5% | +4.2% | +14.0% | +17.9% | |
| Dividend per share | +18.5% | +15.4% | +17.3% | +14.4% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | 91.9% | 68.8% | 87.5% | |
| Return on assets | 17.6% | 21.3% | 28.4% | |
| Current ratio | 3.40 | 2.71 | 2.88 | |
| Debt to equity | 2.21 | – | – | |
| Inventory turnover | 1.8× | 1.9× | 1.5× | |
| Capex to revenue | 1.1% | 3.3% | 2.8% | |
| Diluted shares | 1.57B | 1.55B | 1.32B |
Where the cash went
Fiscal 2022 to 2026, five years combined
KLA generated $18.52B from operations and spent $17.20B on capital expenditure, dividends and share buybacks. 10% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2026 | 35.6% | 0.80× | 3.08× | 87.5% |
| FY2025 | 33.4% | 0.77× | 3.91× | 100.8% |
| FY2024 | 28.1% | 0.67× | 4.69× | 87.8% |
| FY2023 | 32.3% | 0.79× | 6.17× | 156.8% |
| FY2022 | 36.1% | 0.81× | 4.79× | 139.0% |
| FY2021 | 30.0% | 0.71× | 3.24× | 68.8% |
| FY2020 | 21.0% | 0.63× | 3.43× | 45.7% |
| FY2019 | 25.7% | 0.62× | 3.42× | 54.9% |
| FY2018 | 19.9% | 0.72× | 3.79× | 54.4% |
| FY2017 | 26.6% | 0.66× | 5.21× | 91.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
- ProfitableNet income above zero$4.83B
- Cash generatingOperating cash flow above zero$4.14B
- Return on assets improvedROA up on the prior year26.3% → 30.1%
- Earnings backed by cashOperating cash flow above net income$4.14B vs $4.83B
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose2.62 → 2.88
- No dilutionShare count did not rise1.34B → 1.32B
- Gross margin improvedGross margin up on the prior year60.91% → 61.30%
- More efficientAsset turnover rose0.79 → 0.85
See a number that looks wrong?